Hanneke C. Kluin-Nelemans
Hat mitgewirkt an:
-
Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis
-
Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis
-
KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis